Lars Christian Haugli Bråten
- PhD student; MD
- +47 22 11 77 94 / 992 99 034
Lars Christian Bråten has a medical degree from University of Dundee in Scotland from 2005. He has been working with internal medicine, with a special interest in infectious diseases, until he started as a PhD-student in 2015.
Lars Christian Bråten is currently doing his PhD on clinical outcomes of the AIM-study (Antibiotics in Modic changes) – a randomized trial testing antibiotic treatment in patients with chronic low back pain and Modic changes. He is also working on the Backtobasic-study – a randomized trial testing TNF-α inhibitors in patients with chronic low back pain and Modic changes.
Main supervisor/Co supervisor: Kjersti Storheim, John-Anker Zwart, Elina Schistad and Jens Ivar Brox.
Methodology and interests
Lars Christian Bråten has a strong interest in clinical trials and back pain research, and is also involved in radiological and biomedical changes in patients with chronic back pain. He also has a special interest in research on microbiota of the gut and the sputum. He is a member of the National research school in population based epidemiology (EPINOR).
Clinical effect modifiers of antibiotic treatment in patients with chronic low back pain and Modic changes - secondary analyses of a randomised, placebo-controlled trial (the AIM study)
BMC Musculoskelet Disord, 21 (1), 458
Association of Modic change types and their short tau inversion recovery signals with clinical characteristics- a cross sectional study of chronic low back pain patients in the AIM-study
BMC Musculoskelet Disord, 21 (1), 368
Cost-utility analysis of antibiotic treatment in patients with chronic low back pain and Modic changes: results from a randomised, placebo-controlled trial in Norway (the AIM study)
BMJ Open, 10 (6), e035461
Short tau inversion recovery MRI of Modic changes: a reliability study
Acta Radiol Open, 9 (1), 2058460120902402
Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial
BMJ, 367, l5654
[A man in his 30s with fever after a safari in South Africa]
Tidsskr Nor Laegeforen, 136 (4), 328-30